The All Ordinaries Index (ASX: XAO) is up 0.4% on Monday, with one ASX healthcare stock doing plenty of the heavy lifting.

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

In an exercise that is required every five years, Luzerne County is reassessing natural and man-made threats to residents and possible ways to reduce the risks.

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

In 1976, the Eagles released the song, “Life in the Fast Lane,” as part of their iconic album, Hotel California. Approximately 16 years later, ...

The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...

L, a lead ULSC program, following the recent Orphan Drug Designation• Recently reported Phase 1 data of Restem-L demonstrated ...

The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...

Investigational new drug (IND) applications for initiating first-in-human studies for ZW220 and ZW251 in solid tumors anticipated in 2025IND applications for initiating first-in-human studies for ZW20 ...

Aquestive Therapeutics' Anaphylm is nearing FDA approval, potentially disrupting the U.S. anaphylaxis market dominated by ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...